Anavex Life Sciences Announces Preliminary Clinical Efficacy Data of its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients with Rett Syndrome September 16, 2019 - NASDAQ Companies 0 » View More News for September 16, 2019